Terms: = Lung cancer AND NT5C2, ENSG00000076685, 22978, P49902, PNT5, NT5B, GMP, cN-II AND Prognosis
6 results:
1. STING licensing of type I dendritic cells potentiates antitumor immunity.
Wang J; Li S; Wang M; Wang X; Chen S; Sun Z; Ren X; Huang G; Sumer BD; Yan N; Fu YX; Gao J
Sci Immunol; 2024 Feb; 9(92):eadj3945. PubMed ID: 38363830
[TBL] [Abstract] [Full Text] [Related]
2.
He XU; Yu Y; Zhang X; Gao C; Wang H; Liu C
Cancer Genomics Proteomics; 2023; 20(5):476-486. PubMed ID: 37643778
[TBL] [Abstract] [Full Text] [Related]
3. Deciphering the tumor microenvironment cell-infiltrating landscape reveals microenvironment subtypes and therapeutic potentials for nonsquamous NSCLC.
Chen H; Zhang T; Zhang Y; Wu H; Fang Z; Liu Y; Chen Y; Wang Z; Jia S; Ji X; Shang L; Du F; Liu J; Lu M; Chong W
JCI Insight; 2022 Jun; 7(12):. PubMed ID: 35511432
[TBL] [Abstract] [Full Text] [Related]
4. Cytosolic 5'-Nucleotidase II Silencing in a Human lung Carcinoma Cell Line Opposes cancer Phenotype with a Concomitant Increase in p53 Phosphorylation.
Pesi R; Petrotto E; Colombaioni L; Allegrini S; Garcia-Gil M; Camici M; Jordheim LP; Tozzi MG
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30037008
[TBL] [Abstract] [Full Text] [Related]
5. Activated changes of platelet ultra microstructure and plasma granule membrane protein 140 in patients with non-small cell lung cancer.
Zhuge Y; Zhou JY; Yang GD; Zu DL; Xu XL; Tian MQ; Lu GH
Chin Med J (Engl); 2009 May; 122(9):1026-31. PubMed ID: 19493436
[TBL] [Abstract] [Full Text] [Related]
6. Glomeruloid microvascular proliferation is superior to intratumoral microvessel density as a prognostic marker in non-small cell lung cancer.
Tanaka F; Oyanagi H; Takenaka K; Ishikawa S; Yanagihara K; Miyahara R; Kawano Y; Li M; Otake Y; Wada H
Cancer Res; 2003 Oct; 63(20):6791-4. PubMed ID: 14583475
[TBL] [Abstract] [Full Text] [Related]
